Clinical Biochemistry
Clinical Biochemistry
Clinical Biochemistry
Part 2
Engineered Pharmaceuticals in
Medicine and Industry
Synthesis of Pharmaceuticals from Genes Cloned in
Eukaryotes
Some of the human proteins that have been synthesized from genes cloned in eukaryotic cells.
• It doesn't shut down the whole immune system but only inactivates the
WBCs that attack the new organ and doesn’t affect the healthy cells.
• B-lymphocytes bind to cell surface antigen from transplanted cells and
produce cytokine protein (Interleukin 2 or IL 2) that bind to receptors on
T-lymphocytes. The activated T-cells stimulate proliferation and
production of antibodies from B-cells against the transplanted tissues.
• Zenapax works by binding to receptors for IL 2 protein on the surface of
the activated cells only and does not affect the other cells in the immune
system.
• Zenapax showed less kidney rejection (22% of the patients) than the most
commonly used immunosuppressant drug Cyclosporine (35% of patients).
Tissue Transplantation
• Allotransplantation Xenotransplantation